Phase III Randomized Controlled Trial Comparing the Survival of Patients With Unresectable Hepatocellular Carcinoma Treated With Nolatrexed or Doxorubicin

Overview of attention for article published in Journal of Clinical Oncology, July 2007

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

policy: 1 policy source
twitter: 2 X users

patent: 3 patents
guideline: 3 clinical guideline sources

Readers on

mendeley: 147 Mendeley

So far, Altmetric has seen 1 policy document that references this research output.

Sorafenib for treating advanced hepatocellular carcinoma: Committee papers TA189 ACD1 06 May 2009

Cited by National Institute for Health and Care Excellence (NICE) on 31 Aug 2017

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

This page shows the most recent policy documents that mention this research output. Click here to find out how to access more activity.